Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed4
Terminated2

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT02431572Not ApplicableCompleted
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
GlioblastomaIntracranial TumorsMelanoma
PrincipalinvestigatorStart date: 2015-05-01
NCT01105988Early Phase 1Terminated
Evaluating Tumor Pseudoprogression With FLT-PET and MRI
Glioblastoma
Principalinvestigator
NCT01846871Phase 2Completed
Tivozanib for Recurrent Glioblastoma
Glioblastoma
Principalinvestigator
NCT01987830Not ApplicableCompleted
Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
Recurrent Glioblastoma
Principalinvestigator
NCT02076152Not ApplicableCompleted
FMISO PET Study of Glioblastoma
Recurrent Glioblastoma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsRecurrent Glioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaGlioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
16 trials

Shared therapeutic areas:

MelanomaGlioblastoma
Similarity Score12%

Jane Robertson

AstraZeneca

Related
10 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Jinming Yu, PhD

Shandong Cancer Hospital and Institute

Related
8 trials

Shared therapeutic areas:

Glioblastoma
Similarity Score6%

Deborah E Citrin, M.D.

National Cancer Institute (NCI)

Related
13 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Shakeel Modak, MD

Memorial Sloan Kettering Cancer Center

Related
10 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Robert L. DeJager, MD, FACP

Daiichi Sankyo

Related
13 trials

Shared therapeutic areas:

Brain and Central Nervous System Tumors
Similarity Score6%

William D Figg, Pharm.D.

National Cancer Institute (NCI)

Related
11 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Peng Wang, MD

Fudan University

Related
13 trials

Shared therapeutic areas:

Melanoma
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT02431572Not ApplicablePrincipalInvestigator

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

GlioblastomaIntracranial TumorsMelanoma
Completed
NCT00756106Not ApplicablePrincipalInvestigator

MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma

Brain and Central Nervous System Tumors
Terminated
NCT01105988Early Phase 1PrincipalInvestigator

Evaluating Tumor Pseudoprogression With FLT-PET and MRI

Glioblastoma
Terminated
NCT01846871Phase 2PrincipalInvestigator

Tivozanib for Recurrent Glioblastoma

Glioblastoma
Completed
NCT01987830Not ApplicablePrincipalInvestigator

Bevacizumab w / Temozolomide PET & Vascular MRI For GBM

Recurrent Glioblastoma
Completed
NCT02076152Not ApplicablePrincipalInvestigator

FMISO PET Study of Glioblastoma

Recurrent Glioblastoma
Completed

All 6 trials loaded